TOPAMAX (topiramate) intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Trial Profile

TOPAMAX (topiramate) intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2011

At a glance

  • Drugs Topiramate (Primary)
  • Indications Headache disorders; Migraine
  • Focus Therapeutic Use
  • Acronyms INTREPID
  • Sponsors Ortho-McNeil
  • Most Recent Events

    • 28 Feb 2011 Primary endpoint 'Headache-frequency' has not been met
    • 30 Mar 2010 Actual number of patients added to 385 as reported by ClinicalTrials.gov.
    • 30 Mar 2010 Actual end date added to 1 Aug 2007 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top